Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy.

Abstract excerpt

Vitiligo is an acquired chronic depigmenting disorder of the skin, with an estimated prevalence of 0.5% of the general population, characterized by the development of white macules resulting from a loss of epidermal melanocytes. The nomenclature has been revised after an extensive international work within the vitiligo global issues consensus conference, and vitiligo (formerly non-segmental vitiligo) is now a...

Topics

Join the communities discussing this publication.

• Autoimmunity
• Epidermis
• Interferon Type I
• Melanocytes
• Molecular Targeted Therapy